NeuroMetrix Inc at Emerging Growth Conference (Virtual) Transcript
Welcome back, everyone. We have an update from NeuroMetrix, Inc., which trades on the Nasdaq under the symbol, NURO. It is a commercial stage healthcare company that develops and commercializes neuro technology devices to address unmet needs in the chronic pain and diabetes market.
Happy to welcome Dr. Shai Gozani, CEO, for this update. Welcome, Dr.
Thank you, Ana, and thank you for joining us today. So I'll start with the traditional forward-looking statement disclaimer. Please take a look at our recently filed Q and K for a complete listing of risk factors.
So just by way of reminder before I kind of focus in on our core fibromyalgia business, I wanted to remind everyone that at NeuroMetrix, our mission is to improve the lives of patients with complex chronic pain conditions through neuromodulation devices.
And just in terms of our investor thesis, we think it's pretty straightforward. We've had a significant
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
